Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
NeuroSense Therapeutics Achieves FDA Clearance of IND for PrimeC for Treatment of ALS
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) has reported receipt of clearance from the United States Food and Drug Administration to begin a pharmacokinetic study of PrimeC in healthy adult subjects. ...